-Bloomberg
Barclays Downgrades Paychex to Underweight, Lowers Price Target to $110
Barclays analyst Ramsey El-Assal downgrades Paychex (NASDAQ:PAYX) from Equal-Weight to Underweight and lowers the price target from $115 to $110.
Related Posts
Ryder System Beats On Q4; Forecasts Reduced 2023 Earnings On Slowing Macroeconomic & Freight Environment
Ryder System Inc (NYSE:R) reported fourth-quarter FY22 sales growth of 19% year-on-year to $3.09 billion, beating the consensus of $3.04 billion.…
Why Teva Pharmaceuticals Stock Is Soaring After Hours
Teva Pharmaceutical Industries (NYSE: TEVA) shares are surging in Tuesday's after-hours session after the company reported better-than-expected financial results.